Shiga Toxin–Producing Escherichia coli Transmission via Fecal Microbiota Transplant. (29th September 2020)

• Record Type: Journal Article
• Authors: Zellmer, Caroline; Sater, Mohamad R A; Huntley, Miriam H; Osman, Majdi; Olesen, Scott W; Ramakrishna, Bharat
• Is Part Of: Clinical infectious diseases. Volume 72:Number 11(2021)
• Page Start: e876
• Page End: e880
• Publication Date: 2020-09-29
• Subjects: fecal microbiota transplantation -- FMT -- Shiga toxin-producing E. coli -- STEC -- Clostridioides difficile; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciaa1486
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin–producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.